Current status:
Cancelled Post Market
Current status date:
1998-07-30
Product name:
SEREVENT- AEM 25MCG/AEM
DIN:
02136139
Electronic product monograph is not available
Company:
GLAXO CANADA INC
7333 Mississauga Road N.
Mississauga
Ontario
Canada
L5N 6L4
Dosage form(s):
Metered-Dose Aerosol
Route(s) of administration:
Inhalation
,
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
R03AC12 SALMETEROL
List of active ingredient(s)
Active ingredient(s) |
Strength |
SALMETEROL (SALMETEROL XINAFOATE)
|
25 MCG / ACT
|
A Risk Management Plan (RMP) for this product was submitted.